Monoclonal Antibodies Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Improve Biologic Modalities Manufacturing for mAb Readiness

August 18, 2026

Ebglyss (Lebrikizumab) Approval Adds 8-Week Maintenance Option for Eczema

Generate Biomedicines IPO Raises $400M with Phase III Asthma Therapy in Pipeline

Sanofi’s Cablivi Becomes First FDA-Approved Treatment for Pediatric aTTP

January 9, 2026

FDA Approves Yartemlea for Rare, Life-Threatening Stem Cell Transplant Complication

January 8, 2026

FDA Moves to Limit Certain Long-Term Non-Human Primate Studies

December 5, 2025

Bioinformatics: A Vital Precursor to Successful Biomanufacturing

November 24, 2025

Keytruda Qlex Wins FDA Approval, Enabling One- to Two-Minute Pembrolizumab Delivery

October 16, 2025

GSK Ends Cobolimab NSCLC Program After Mid-Stage Trial Results

August 11, 2025

Life Science Spotlight

From Concept to Clinic: Are We Making the Right First Moves in Bispecific Development?

August 11, 2025

FDA Approves Gamifant (Emapalumab), First Therapy for Macrophage Activation Syndrome in Still’s Disease

Accelerating FIH Biologics Manufacturing with Membrane Protein A Chromatography

Starjemza (Ustekinumab) FDA Approval: 2025’s First Biosimilar for Stelara in Psoriasis Care

World Lupus Day 2025: Emerging Pipeline Advances from Biopharma

Imaavy, J&J’s New FcRn Blocker for gMG, Approved by FDA

FDA Animal Testing Phase-Out Targets Monoclonal Antibodies

Next Page »